As MarketWatch’s sister publication
Barron’s writes,
the Sino-American issues are many and include actions taken by the U.S.
to censure China’s new security rules that threaten Hong Kong’s
semiautonomous status, restrictions against Huawei Technologies, a push
to increase
scrutiny of Chinese companies listed in
the U.S., funding for the World Health Organization, and accountability
for the handling of the viral outbreak that has likely ushered in one
of the most severe global recessions in the past 100 years.
“The list is long as my arm,” said Ian Bremmer, Eurasia Group’s
founder and president, of the Sino-American tensions, during a Friday
interview on CNBC.
“It’s never a good thing that the two largest economies in the
world are battling,” Peter Boockvar, chief investment officer of
Bleakley Advisory Group, told MarketWatch in an emailed exchange on
Friday.
Tensions between the countries, however, don’t seem to have
supplanted the intense investor focus on reopening the economy in the
U.S., and elsewhere in the world, or attention on a cure for the
COVID-19 pandemic, which have helped to buoy risk assets.
“I think the market likely sees the upside risk related to finding a
vaccine or treatment as near-term, and the downside risk related to
China as long-term, so they are focusing more on the near-term right
now,” Lindsey Bell, chief investment strategist with Ally Invest, told
MarketWatch on Friday.
“After a 30% plus rally from the March lows, the bar is definitely
much higher. As the worries with China heat up, we do think investors
could be a little too complacent here and now,” said Ryan Detrick,
senior market strategist at LPL Financial.
“The economic recovery is still very fragile and any larger
repercussions between the U.S. and China could put a halt to the equity
rally quite quickly,” he told MarketWatch.
Read more at: Are stock investors too complacent about a full-scale blowup between China and the U.S.? Here’s what Wall Street experts say - MarketWatch